Lupus (SLE) trials in Malaysia
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peoplePhase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Where
- Ipoh
- Age
- 12 years to 100 years
- People
- 550 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06133972 · EU 2023-505929-14-00 - Phase 3Taking peoplePhase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
- Where
- Kuala Lumpur, Sibu
- Age
- 18 years to 100 years
- People
- 348 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06711887 · EU 2024-515280-60-00 - Phase 3Taking peopleA Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Where
- Johor Bahru, Kuala, Kuala Lumpur, Kuching, Petaling Jaya, Taiping
- Age
- 18 years to 75 years
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07438496 · EU 2025-523552-31-00 - Phase 3Enrolling by invitationLong-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
- Where
- Kuching
- Age
- 18 years to 75 years
- People
- 680 worldwide
- Run by
- Viatris Innovation GmbH
See details and how to joinNCT06475742 · EU 2024-514354-67-00 - Phase 1Taking peopleAutologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)
- Where
- Bandar Tun Razak
- Age
- 18 years to 65 years
- People
- 5
- Run by
- National University of Malaysia
See details and how to joinNCT06710717